JP2025505638A5 - - Google Patents

Info

Publication number
JP2025505638A5
JP2025505638A5 JP2024546369A JP2024546369A JP2025505638A5 JP 2025505638 A5 JP2025505638 A5 JP 2025505638A5 JP 2024546369 A JP2024546369 A JP 2024546369A JP 2024546369 A JP2024546369 A JP 2024546369A JP 2025505638 A5 JP2025505638 A5 JP 2025505638A5
Authority
JP
Japan
Application number
JP2024546369A
Other languages
Japanese (ja)
Other versions
JP2025505638A (ja
JPWO2023154307A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/012576 external-priority patent/WO2023154307A1/en
Publication of JP2025505638A publication Critical patent/JP2025505638A/ja
Publication of JP2025505638A5 publication Critical patent/JP2025505638A5/ja
Publication of JPWO2023154307A5 publication Critical patent/JPWO2023154307A5/ja
Pending legal-status Critical Current

Links

JP2024546369A 2022-02-09 2023-02-08 抗体コンジュゲート8-スルホニル-ベンザゼピン化合物及びそれらの使用 Pending JP2025505638A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263308275P 2022-02-09 2022-02-09
US63/308,275 2022-02-09
PCT/US2023/012576 WO2023154307A1 (en) 2022-02-09 2023-02-08 Antibody-conjugated 8-sulfonyl-benzazepine compounds and their uses

Publications (3)

Publication Number Publication Date
JP2025505638A JP2025505638A (ja) 2025-02-28
JP2025505638A5 true JP2025505638A5 (https=) 2026-02-12
JPWO2023154307A5 JPWO2023154307A5 (https=) 2026-02-12

Family

ID=85778754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024546369A Pending JP2025505638A (ja) 2022-02-09 2023-02-08 抗体コンジュゲート8-スルホニル-ベンザゼピン化合物及びそれらの使用

Country Status (10)

Country Link
US (1) US20250127914A1 (https=)
EP (1) EP4475893A1 (https=)
JP (1) JP2025505638A (https=)
KR (1) KR20240139086A (https=)
CN (1) CN118843481A (https=)
AU (1) AU2023216956A1 (https=)
IL (1) IL314755A (https=)
MX (1) MX2024009756A (https=)
TW (1) TW202339806A (https=)
WO (1) WO2023154307A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026050213A1 (en) * 2024-08-27 2026-03-05 Usbolt Biotherapeutics, Inc. Tlr agonist immunoconjugates and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3233835B1 (en) * 2014-12-18 2019-01-23 F.Hoffmann-La Roche Ag Benzazepine sulfonamide compounds
CN108055842B (zh) * 2015-09-17 2021-06-29 豪夫迈·罗氏有限公司 亚磺酰基苯基或磺亚胺酰基苯基苯并氮杂䓬
EP3464274B1 (en) * 2016-05-23 2020-05-27 H. Hoffnabb-La Roche Ag Benzazepine dicarboxamide compounds with secondary amide function
AU2019337654A1 (en) * 2018-09-12 2021-04-08 Silverback Therapeutics, Inc. Substituted benzazepine compounds, conjugates, and uses thereof
AU2020291014B2 (en) * 2019-06-13 2025-06-05 Bolt Biotherapeutics, Inc. Aminobenzazepine compounds, immunoconjugates, and uses thereof
JP2022549510A (ja) * 2019-09-30 2022-11-25 ボルト バイオセラピューティクス、インコーポレーテッド アミド結合したアミノベンズアゼピン免疫複合体、及びその使用
JP7735291B2 (ja) * 2020-02-21 2025-09-08 エーアールエス ファーマシューティカルズ、インコーポレイテッド ネクチン-4抗体コンジュゲートおよびその使用
CN115996756A (zh) * 2020-05-08 2023-04-21 博尔特生物治疗药物有限公司 弹性蛋白酶底物肽连接子免疫缀合物及其用途

Similar Documents

Publication Publication Date Title
JP2025505638A5 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
JP2025507316A5 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BY13176U (https=)
BY13166U (https=)
CN307045806S (https=)
CN307045653S (https=)
CN307045364S (https=)
CN307044521S (https=)
BY13141U (https=)
CN307046023S (https=)
BY23963C1 (https=)
CN307046678S (https=)
CN307046879S (https=)
BY13164U (https=)